Vivo Surgical Announces Leading Gastrointestinal Endoscopists on Clinical Advisory Board for Novel Endoscopic Robot

Inaugural international clinical advisory board to provide strategic guidance towards development of the company's ERESTM endoscopic robot SINGAPORE , May 2, 2024 /PRNewswire/ -- Vivo Surgical Private Limited, a privately-held surgical technology company pioneering a flexible endoscopic robot for advanced endoscopic resections, is excited to unveil its inaugural International Clinical Advisory Board. Comprising distinguished Key Opinion Leaders (KOLs) in the field of therapeutic gastrointestinal (GI) endoscopy, the board is poised to provide strategic guidance and expertise to Vivo Surgical as it continues to drive advancements in minimally invasive surgical robotic technology. The inaugural members of the International Clinical Advisory Board are: Dr (Prof) Yutaka Saito , MD PhD Dr Saito is internationally recognized for his expertise in the fields of colonoscopy, advanced endoscopic imaging and endoscopic submucosal dissection (ESD).

At present, he is Director of the Endoscopy Center at the National Cancer Center Hospital ( Tokyo, Japan ), serving also as Chief of its Endoscopy Division. Dr Saito holds fellowships in several prominent gastroenterological societies, such as the American Society for Gastrointestinal Endoscopy (FASGE) and Japanese Gastrointestinal Endoscopy Society (FJGES), and was honoured with the UAB Basil Hirschowitz Master Endoscopist Award for his global contributions to the advancement of endoscopy. Dr (Prof) Pinghong Zhou, MD Dr Zhou holds esteemed pos.